COMP <GO>
BLCO vs JNJ // EV/EBITDA & P/E VALUATION
Bausch + Lomb Corporation (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BLCO 3
— JNJ 10
▲ EV/EBITDA & P/E VALUATION LEADER: JNJ
LAST: $20.00 (-1.96%) • MKT CAP: $7.29B
valuation
29.1x
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
valuation
18.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLCO VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLCO | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | 25.50% | -24.70 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 29.1x | 18.5x | +10.60 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | -0.90% | 2.97% | -3.87 | JNJ | /fcf-yield <GO> |
| Operating Margin | 2.20% | 34.70% | -32.50 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -7.10% | 28.50% | -35.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 6.00% | +0.50 | BLCO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.97 | 5.59 | -4.62 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 7.20% | -0.10 | BLCO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.8 | 60.4 | +13.50 | BLCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.08 | -0.02 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 23.0x | 0.00 | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.29B | $662.49B | -$655.20B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLCO REV | JNJ REV | BLCO GROSS % | JNJ GROSS % | BLCO FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.10B | $94.19B | 44.0% | 67.9% | -$66.0M | $19.70B |
| FY 2024 | $4.79B | $88.82B | 44.0% | 69.1% | -$59.0M | $19.84B |
| FY 2023 | $4.15B | $85.16B | 44.0% | 44.0% | -$203.6M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLCO // BETA 1.06
JNJ // BETA 1.08